TCMD earnings analysis
What we found in TCMD's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The supplied 10-Q excerpt provides no income statement, balance-sheet, cash-flow, segment, or quantitative guidance data, so operating trends cannot be assessed from the filing text provided. It does show 208,900 shares repurchased during the quarter and $18.651 million remaining under the $25.0 million authorization. Controls were effective as of June 30, 2026, and management reported no material changes to internal controls or risk factors from the December 31, 2025 disclosures.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Share repurchases resumed
- The company repurchased 208,900 shares during the quarter ended June 30, 2026, including 158,900 shares in April and 50,000 shares in June.
- Meaningful buyback capacity remains
- The company had $18.651 million remaining under its repurchase authorization at June 30, 2026, compared with the original program authorization of $25.0 million.
- Disclosure controls effective
- Management concluded that disclosure controls and procedures were effective at the reasonable assurance level as of June 30, 2026.
- No material control changes
- The company reported no changes during the quarter ended June 30, 2026, that materially affected or were reasonably likely to materially affect internal control over financial reporting.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- No updated risk-factor detail
- The filing states that there were no material changes in risk factors from those disclosed in the Annual Report on Form 10-K for the year ended December 31, 2025; therefore, no new or revised risk-factor disclosures were identified.
- Legal exposure not quantified
- The filing incorporates legal-proceeding information from Note 9, Commitments and Contingencies, but the supplied excerpt does not quantify any related exposure.
- Cash allocation from buybacks
- The company repurchased 208,900 shares during the quarter, reducing the remaining authorization to $18.651 million from the $25.0 million program authorization; continued repurchases could reduce cash available for other uses.
What they said about what is next.
The provided 10-Q excerpt does not include quantitative revenue or EPS guidance. No forward outlook, liquidity outlook, or capital-spending forecast is disclosed in the supplied text.
The filing reads about the same as the one before it.
What came before.
- 10-Q · May 4, 2026
- In the first quarter of 2026, TCMD reported revenue of $75.3 million, a significant increase of 23% from $61.3 million in Q1 2025. Despite growing revenues, a net loss of $1.8 million was recorded, though this was an…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing TCMD makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever